This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Parseval, A.
Right arrow Articles by Elder, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Parseval, A.
Right arrow Articles by Elder, J. H.

 Previous Article  |  Next Article 

Journal of Virology, January 1999, p. 608-617, Vol. 73, No. 1
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Demonstration that orf2 Encodes the Feline Immunodeficiency Virus Transactivating (Tat) Protein and Characterization of a Unique Gene Product with Partial Rev Activity

Aymeric de Parseval and John H. Elder*

Department of Molecular Biology, The Scripps Research Institute, La Jolla, California 92037

Received 28 May 1998/Accepted 5 October 1998

The long PCR technique was used to amplify the three size classes of viral mRNAs produced in cells infected by feline immunodeficiency virus (FIV). We identified in the env region a new splice acceptor site that generated two transcripts, each coding for an 11-kDa protein, p11rev, whose function is unknown. The small-size class of mRNAs included two bicistronic orf2/rev mRNAs and two rev-like mRNAs, consisting only of the second exon of rev and coding for a 15-kDa protein, p15rev. p15rev contained the minimal effector domain of Rev and was sufficient to mediate partial Rev activity. The bicistronic mRNAs encoded two distinct proteins, one of 23 kDa corresponding to Rev and a 9-kDa protein encoded by the orf2 gene. The orf2 gene product is a protein of 79 amino acids with characteristics similar to those of the Tat (transactivator) proteins of the ungulate lentiviruses. Transient expression assays, using the FIV long terminal repeat (LTR) to drive transcription of the bacterial gene for chloramphenicol acetyltransferase demonstrated that the orf2 gene transactivates gene expression an average of 14- to 20-fold above the basal level. Deletion mutants of the FIV LTR were generated to locate sequences responsive to transactivation mediated by the orf2 gene. A 5' deletion mutant that removed the AP1 site resulted in residual low-level transactivation by orf2. Further experiments using LTR mutants with internal deletions identified three regions located between positions -126 and -47 relative to the cap site that were important for orf2-directed transactivation. These regions include the AP1 site, a C/EBP tandem repeat, and an ATF site.

* Corresponding author. Mailing address: The Scripps Research Institute, Department of Molecular Biology, 10550 N. Torrey Pines Rd., La Jolla, CA 92037. Phone: (619) 784-8270. Fax: (619) 784-2750. E-mail: jelder{at}scripps.edu.

Journal of Virology, January 1999, p. 608-617, Vol. 73, No. 1
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • de Rozieres, S., Thompson, J., Sundstrom, M., Gruber, J., Stump, D. S., de Parseval, A. P., VandeWoude, S., Elder, J. H. (2008). Replication Properties of Clade A/C Chimeric Feline Immunodeficiency Viruses and Evaluation of Infection Kinetics in the Domestic Cat. J. Virol. 82: 7953-7963 [Abstract] [Full Text]  
  • James, L., Sargueil, B. (2008). RNA secondary structure of the feline immunodeficiency virus 5'UTR and Gag coding region. Nucleic Acids Res 36: 4653-4666 [Abstract] [Full Text]  
  • Omoto, S., Brisibe, E. A., Okuyama, H., Fujii, Y. R. (2004). Feline foamy virus Tas protein is a DNA-binding transactivator. J. Gen. Virol. 85: 2931-2935 [Abstract] [Full Text]  
  • de Rozieres, S., Mathiason, C. K., Rolston, M. R., Chatterji, U., Hoover, E. A., Elder, J. H. (2004). Characterization of a Highly Pathogenic Molecular Clone of Feline Immunodeficiency Virus Clade C. J. Virol. 78: 8971-8982 [Abstract] [Full Text]  
  • Gemeniano, M. C., Sawai, E. T., Leutenegger, C. M., Sparger, E. E. (2003). Feline Immunodeficiency Virus Orf-A Is Required for Virus Particle Formation and Virus Infectivity. J. Virol. 77: 8819-8830 [Abstract] [Full Text]  
  • Chatterji, U., de Parseval, A., Elder, J. H. (2002). Feline Immunodeficiency Virus OrfA Is Distinct from Other Lentivirus Transactivators. J. Virol. 76: 9624-9634 [Abstract] [Full Text]  
  • Brooks, A. I., Stein, C. S., Hughes, S. M., Heth, J., McCray, P. M. Jr., Sauter, S. L., Johnston, J. C., Cory-Slechta, D. A., Federoff, H. J., Davidson, B. L. (2002). From the Cover: Functional correction of established central nervous system deficits in an animal model of lysosomal storage disease with feline immunodeficiency virus-based vectors. Proc. Natl. Acad. Sci. USA 99: 6216-6221 [Abstract] [Full Text]  
  • Norway, R. M., Crawford, P. C., Johnson, C. M., Mergia, A. (2001). Thymic Lesions in Cats Infected with a Pathogenic Molecular Clone or an ORF-A/2-Deficient Molecular Clone of Feline Immunodeficiency Virus. J. Virol. 75: 5833-5841 [Abstract] [Full Text]  
  • Browning, M. T., Schmidt, R. D., Lew, K. A., Rizvi, T. A. (2001). Primate and Feline Lentivirus Vector RNA Packaging and Propagation by Heterologous Lentivirus Virions. J. Virol. 75: 5129-5140 [Abstract] [Full Text]  
  • Bigornia, L., Lockridge, K. M., Sparger, E. E. (2001). Construction and In Vitro Characterization of Attenuated Feline Immunodeficiency Virus Long Terminal Repeat Mutant Viruses. J. Virol. 75: 1054-1060 [Abstract] [Full Text]  
  • Miller, R. J., Cairns, J. S., Bridges, S., Sarver, N. (2000). Human Immunodeficiency Virus and AIDS: Insights from Animal Lentiviruses. J. Virol. 74: 7187-7195 [Full Text]  
  • Barboric, M., Taube, R., Nekrep, N., Fujinaga, K., Peterlin, B. M. (2000). Binding of Tat to TAR and Recruitment of Positive Transcription Elongation Factor b Occur Independently in Bovine Immunodeficiency Virus. J. Virol. 74: 6039-6044 [Abstract] [Full Text]  
  • Bogerd, H. P., Wiegand, H. L., Bieniasz, P. D., Cullen, B. R. (2000). Functional Differences between Human and Bovine Immunodeficiency Virus Tat Transcription Factors. J. Virol. 74: 4666-4671 [Abstract] [Full Text]  
  • Chen, H., He, J., Fong, S., Wilcox, G., Wood, C. (2000). Jembrana Disease Virus Tat Can Regulate Human Immunodeficiency Virus (HIV) Long Terminal Repeat-Directed Gene Expression and Can Substitute for HIV Tat in Viral Replication. J. Virol. 74: 2703-2713 [Abstract] [Full Text]  
  • Johnston, J. C., Gasmi, M., Lim, L. E., Elder, J. H., Yee, J.-K., Jolly, D. J., Campbell, K. P., Davidson, B. L., Sauter, S. L. (1999). Minimum Requirements for Efficient Transduction of Dividing and Nondividing Cells by Feline Immunodeficiency Virus Vectors. J. Virol. 73: 4991-5000 [Abstract] [Full Text]  
  • Brooks, A. I., Stein, C. S., Hughes, S. M., Heth, J., McCray, P. M. Jr., Sauter, S. L., Johnston, J. C., Cory-Slechta, D. A., Federoff, H. J., Davidson, B. L. (2002). From the Cover: Functional correction of established central nervous system deficits in an animal model of lysosomal storage disease with feline immunodeficiency virus-based vectors. Proc. Natl. Acad. Sci. USA 99: 6216-6221 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»